# Zylox-Tonbridge and GL Capital invest US$189M in LifeTech Scientific

Zylox-Tonbridge Medical Technology and GL Capital will jointly invest approximately HK$1.48 billion (US$189 million) in LifeTech Scientific through GL Lighthouse Two Investment. Lighthouse Two will subscribe for newly issued shares representing about 16.7% of LifeTech's enlarged share capital. Separately, GL Capital will acquire 39.8 million newly issued Zylox-Tonbridge shares.

- Type: Investment
- Announced: 2026-11-11
- Where: China
- Value: $189.0M
- Status: announced
- Products: vascular and structural heart devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LifeTech Scientific](https://endata.com/companies/38475.md) (target)
- [Zylox-Tonbridge Medical Technology](https://endata.com/companies/94974.md) (investor)
- [GL Capital](https://endata.com/companies/94975.md) (investor)

## Sources

- [healthcaremea.com](https://www.healthcaremea.com/2026/11/11/zylox-tonbridge-explores-lifetech-merger-after-us189m-investment-deal-in-china/), 2026-11-11: "The investment aims to bring the two medical device manufacturers closer together and establish an integrated platform covering vascular and structural heart interventions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.